| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ischemia | 54 | 2024 | 337 | 12.840 |
Why?
|
| Diabetic Foot | 58 | 2023 | 156 | 11.030 |
Why?
|
| Peripheral Arterial Disease | 46 | 2024 | 269 | 10.200 |
Why?
|
| Limb Salvage | 44 | 2024 | 119 | 7.180 |
Why?
|
| Vascular Surgical Procedures | 46 | 2024 | 565 | 6.210 |
Why?
|
| Endovascular Procedures | 43 | 2024 | 718 | 5.380 |
Why?
|
| Lower Extremity | 22 | 2023 | 178 | 5.160 |
Why?
|
| Wound Healing | 28 | 2024 | 451 | 4.200 |
Why?
|
| Blood Vessel Prosthesis Implantation | 19 | 2020 | 786 | 2.450 |
Why?
|
| Arterial Occlusive Diseases | 8 | 2019 | 127 | 2.320 |
Why?
|
| Leg | 10 | 2023 | 154 | 2.270 |
Why?
|
| Wound Infection | 7 | 2018 | 52 | 2.270 |
Why?
|
| Diabetic Angiopathies | 7 | 2023 | 59 | 1.980 |
Why?
|
| Foot Ulcer | 8 | 2023 | 19 | 1.890 |
Why?
|
| Vascular Patency | 20 | 2020 | 202 | 1.870 |
Why?
|
| Treatment Outcome | 74 | 2024 | 12102 | 1.870 |
Why?
|
| Risk Factors | 57 | 2024 | 10001 | 1.810 |
Why?
|
| Peripheral Vascular Diseases | 8 | 2023 | 89 | 1.660 |
Why?
|
| Foot | 8 | 2023 | 63 | 1.560 |
Why?
|
| Stents | 16 | 2023 | 866 | 1.530 |
Why?
|
| Time Factors | 43 | 2024 | 6201 | 1.510 |
Why?
|
| Angioplasty, Balloon | 4 | 2019 | 161 | 1.510 |
Why?
|
| Risk Assessment | 28 | 2024 | 3332 | 1.500 |
Why?
|
| Arteriovenous Shunt, Surgical | 7 | 2023 | 94 | 1.400 |
Why?
|
| Evidence-Based Medicine | 7 | 2024 | 619 | 1.380 |
Why?
|
| Humans | 177 | 2024 | 123177 | 1.370 |
Why?
|
| Vascular Grafting | 5 | 2019 | 44 | 1.350 |
Why?
|
| Aneurysm | 3 | 2017 | 88 | 1.350 |
Why?
|
| Predictive Value of Tests | 14 | 2024 | 2108 | 1.340 |
Why?
|
| Aortic Aneurysm, Abdominal | 8 | 2022 | 439 | 1.280 |
Why?
|
| Terminology as Topic | 4 | 2019 | 229 | 1.270 |
Why?
|
| Diabetes Mellitus | 11 | 2023 | 850 | 1.260 |
Why?
|
| Decision Support Techniques | 5 | 2024 | 280 | 1.250 |
Why?
|
| Aged | 65 | 2024 | 19065 | 1.220 |
Why?
|
| Severity of Illness Index | 16 | 2024 | 2838 | 1.170 |
Why?
|
| Tibial Arteries | 5 | 2012 | 10 | 1.160 |
Why?
|
| Vascular System Injuries | 6 | 2021 | 50 | 1.160 |
Why?
|
| Mesenteric Ischemia | 3 | 2018 | 30 | 1.160 |
Why?
|
| Middle Aged | 65 | 2024 | 25973 | 1.130 |
Why?
|
| Intermittent Claudication | 8 | 2022 | 54 | 1.080 |
Why?
|
| Iliac Artery | 3 | 2019 | 92 | 1.070 |
Why?
|
| Iliac Aneurysm | 4 | 2011 | 31 | 1.050 |
Why?
|
| Retrospective Studies | 46 | 2024 | 15979 | 1.030 |
Why?
|
| Aged, 80 and over | 34 | 2023 | 6368 | 1.010 |
Why?
|
| Male | 87 | 2024 | 60015 | 0.960 |
Why?
|
| Chronic Disease | 12 | 2024 | 1167 | 0.960 |
Why?
|
| Anemia | 2 | 2019 | 339 | 0.940 |
Why?
|
| Podiatry | 5 | 2016 | 7 | 0.920 |
Why?
|
| Aneurysm, Infected | 3 | 2009 | 25 | 0.910 |
Why?
|
| Practice Guidelines as Topic | 12 | 2024 | 1259 | 0.910 |
Why?
|
| Femoral Artery | 8 | 2022 | 190 | 0.890 |
Why?
|
| Saphenous Vein | 3 | 2013 | 53 | 0.890 |
Why?
|
| Practice Patterns, Physicians' | 7 | 2021 | 711 | 0.890 |
Why?
|
| Veins | 5 | 2023 | 106 | 0.880 |
Why?
|
| Celiac Artery | 4 | 2018 | 28 | 0.880 |
Why?
|
| Postoperative Complications | 13 | 2020 | 3007 | 0.880 |
Why?
|
| Arteries | 6 | 2023 | 222 | 0.850 |
Why?
|
| Ultrasonography, Doppler, Duplex | 7 | 2013 | 50 | 0.800 |
Why?
|
| Specialties, Surgical | 6 | 2020 | 79 | 0.800 |
Why?
|
| Drug-Eluting Stents | 3 | 2020 | 53 | 0.800 |
Why?
|
| Patient Care Team | 7 | 2012 | 547 | 0.800 |
Why?
|
| Renal Dialysis | 5 | 2019 | 842 | 0.800 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2020 | 122 | 0.790 |
Why?
|
| Popliteal Artery | 6 | 2013 | 53 | 0.760 |
Why?
|
| Female | 76 | 2024 | 65423 | 0.740 |
Why?
|
| Extremities | 2 | 2020 | 82 | 0.700 |
Why?
|
| Societies, Medical | 9 | 2021 | 680 | 0.670 |
Why?
|
| Mesenteric Artery, Superior | 2 | 2018 | 35 | 0.650 |
Why?
|
| Blood Vessel Prosthesis | 7 | 2019 | 524 | 0.650 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2019 | 42 | 0.650 |
Why?
|
| Constriction, Pathologic | 4 | 2015 | 238 | 0.650 |
Why?
|
| Vascular Access Devices | 1 | 2019 | 35 | 0.650 |
Why?
|
| Carotid Stenosis | 2 | 2019 | 133 | 0.630 |
Why?
|
| Paclitaxel | 1 | 2019 | 122 | 0.630 |
Why?
|
| Kaplan-Meier Estimate | 11 | 2024 | 1005 | 0.620 |
Why?
|
| Angioplasty | 4 | 2013 | 85 | 0.610 |
Why?
|
| Cardiovascular Agents | 1 | 2019 | 86 | 0.610 |
Why?
|
| Myocardial Infarction | 4 | 2022 | 998 | 0.610 |
Why?
|
| Upper Extremity | 2 | 2009 | 53 | 0.600 |
Why?
|
| Patient Participation | 1 | 2020 | 220 | 0.600 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 225 | 0.590 |
Why?
|
| Femoral Vein | 2 | 2017 | 50 | 0.590 |
Why?
|
| General Surgery | 1 | 2019 | 203 | 0.570 |
Why?
|
| Leg Ulcer | 2 | 2023 | 11 | 0.570 |
Why?
|
| Patient Selection | 7 | 2021 | 685 | 0.560 |
Why?
|
| Cardiac Rehabilitation | 1 | 2017 | 24 | 0.560 |
Why?
|
| Axillary Artery | 3 | 2015 | 27 | 0.560 |
Why?
|
| Logistic Models | 10 | 2019 | 1799 | 0.550 |
Why?
|
| Aneurysm, False | 2 | 2023 | 101 | 0.550 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2016 | 20 | 0.540 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2018 | 205 | 0.540 |
Why?
|
| Percutaneous Coronary Intervention | 2 | 2017 | 228 | 0.540 |
Why?
|
| Health Care Costs | 2 | 2016 | 365 | 0.530 |
Why?
|
| Attitude of Health Personnel | 2 | 2021 | 640 | 0.530 |
Why?
|
| Cardiovascular Diseases | 4 | 2023 | 1861 | 0.520 |
Why?
|
| Toes | 3 | 2016 | 26 | 0.510 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2021 | 825 | 0.500 |
Why?
|
| Caregivers | 1 | 2020 | 564 | 0.490 |
Why?
|
| Aorta, Thoracic | 3 | 2022 | 517 | 0.490 |
Why?
|
| Nervous System Diseases | 1 | 2019 | 370 | 0.480 |
Why?
|
| United States | 28 | 2023 | 10618 | 0.480 |
Why?
|
| Resuscitation Orders | 1 | 2015 | 32 | 0.480 |
Why?
|
| Critical Illness | 9 | 2019 | 595 | 0.470 |
Why?
|
| Vascular Diseases | 3 | 2021 | 163 | 0.470 |
Why?
|
| Odds Ratio | 6 | 2018 | 1245 | 0.470 |
Why?
|
| Length of Stay | 9 | 2020 | 1284 | 0.470 |
Why?
|
| Metatarsal Bones | 2 | 2022 | 8 | 0.460 |
Why?
|
| Vena Cava, Inferior | 2 | 2018 | 100 | 0.460 |
Why?
|
| Popliteal Vein | 1 | 2013 | 9 | 0.460 |
Why?
|
| Fractures, Closed | 1 | 2013 | 9 | 0.450 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2014 | 2043 | 0.450 |
Why?
|
| Patient Readmission | 3 | 2018 | 365 | 0.450 |
Why?
|
| Regional Blood Flow | 8 | 2017 | 211 | 0.440 |
Why?
|
| Prosthesis Design | 8 | 2020 | 667 | 0.440 |
Why?
|
| Prognosis | 11 | 2023 | 4508 | 0.430 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2023 | 1225 | 0.430 |
Why?
|
| Perfusion Imaging | 1 | 2013 | 11 | 0.430 |
Why?
|
| Chi-Square Distribution | 9 | 2018 | 587 | 0.420 |
Why?
|
| Tibial Fractures | 1 | 2013 | 59 | 0.420 |
Why?
|
| Education, Medical, Graduate | 3 | 2012 | 510 | 0.420 |
Why?
|
| Occlusive Dressings | 4 | 2009 | 6 | 0.420 |
Why?
|
| Coloring Agents | 1 | 2013 | 77 | 0.420 |
Why?
|
| Heart Diseases | 1 | 2017 | 483 | 0.420 |
Why?
|
| Precision Medicine | 1 | 2016 | 313 | 0.410 |
Why?
|
| Metatarsophalangeal Joint | 1 | 2012 | 3 | 0.410 |
Why?
|
| Gangrene | 4 | 2023 | 26 | 0.410 |
Why?
|
| Arthroplasty | 1 | 2012 | 16 | 0.410 |
Why?
|
| Indocyanine Green | 1 | 2013 | 58 | 0.410 |
Why?
|
| Surgical Wound Infection | 2 | 2012 | 260 | 0.400 |
Why?
|
| Reoperation | 8 | 2013 | 819 | 0.400 |
Why?
|
| Joint Diseases | 1 | 2012 | 33 | 0.400 |
Why?
|
| Aortic Diseases | 2 | 2019 | 197 | 0.390 |
Why?
|
| Radiography | 8 | 2015 | 818 | 0.380 |
Why?
|
| Quality Indicators, Health Care | 3 | 2020 | 214 | 0.380 |
Why?
|
| Fluorescein Angiography | 1 | 2012 | 138 | 0.370 |
Why?
|
| Proportional Hazards Models | 8 | 2024 | 1305 | 0.370 |
Why?
|
| Registries | 10 | 2020 | 1390 | 0.370 |
Why?
|
| International Cooperation | 3 | 2020 | 160 | 0.360 |
Why?
|
| Mammary Arteries | 1 | 2010 | 26 | 0.360 |
Why?
|
| Aneurysm, Ruptured | 1 | 2010 | 36 | 0.360 |
Why?
|
| Wounds, Penetrating | 2 | 2023 | 139 | 0.350 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 2020 | 792 | 0.350 |
Why?
|
| Balloon Occlusion | 2 | 2009 | 43 | 0.340 |
Why?
|
| Frailty | 2 | 2022 | 97 | 0.340 |
Why?
|
| Reproducibility of Results | 6 | 2023 | 2851 | 0.330 |
Why?
|
| Hospital Mortality | 7 | 2019 | 1004 | 0.330 |
Why?
|
| Endocrinology | 3 | 2010 | 139 | 0.330 |
Why?
|
| Frail Elderly | 3 | 2020 | 94 | 0.330 |
Why?
|
| Fellowships and Scholarships | 1 | 2012 | 272 | 0.320 |
Why?
|
| Hemostasis | 1 | 2009 | 69 | 0.320 |
Why?
|
| Atherectomy | 1 | 2008 | 12 | 0.320 |
Why?
|
| Marfan Syndrome | 1 | 2010 | 137 | 0.320 |
Why?
|
| Glomus Tumor | 1 | 2008 | 13 | 0.320 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2014 | 654 | 0.310 |
Why?
|
| Ankle Brachial Index | 5 | 2023 | 38 | 0.310 |
Why?
|
| Monitoring, Physiologic | 2 | 2020 | 355 | 0.300 |
Why?
|
| Intestinal Fistula | 1 | 2008 | 28 | 0.300 |
Why?
|
| Recurrence | 5 | 2016 | 1420 | 0.300 |
Why?
|
| Adult | 25 | 2023 | 29032 | 0.300 |
Why?
|
| Arizona | 6 | 2015 | 25 | 0.300 |
Why?
|
| Healthcare Disparities | 3 | 2017 | 418 | 0.290 |
Why?
|
| Foot Diseases | 2 | 2023 | 24 | 0.290 |
Why?
|
| Vascular Fistula | 1 | 2008 | 30 | 0.290 |
Why?
|
| Colonic Diseases | 1 | 2008 | 38 | 0.290 |
Why?
|
| Education, Medical, Continuing | 1 | 2008 | 140 | 0.290 |
Why?
|
| Internship and Residency | 3 | 2012 | 1158 | 0.290 |
Why?
|
| Treatment Failure | 5 | 2009 | 338 | 0.280 |
Why?
|
| Aorta, Abdominal | 2 | 2018 | 120 | 0.280 |
Why?
|
| Median Arcuate Ligament Syndrome | 2 | 2017 | 5 | 0.280 |
Why?
|
| Aortic Aneurysm | 1 | 2009 | 224 | 0.280 |
Why?
|
| Multivariate Analysis | 5 | 2017 | 1418 | 0.270 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2016 | 51 | 0.270 |
Why?
|
| Survival Rate | 4 | 2019 | 1995 | 0.270 |
Why?
|
| Sepsis | 3 | 2015 | 479 | 0.270 |
Why?
|
| User-Computer Interface | 2 | 2020 | 153 | 0.270 |
Why?
|
| Trauma Centers | 3 | 2017 | 171 | 0.260 |
Why?
|
| Follow-Up Studies | 9 | 2019 | 5047 | 0.260 |
Why?
|
| Incidence | 6 | 2021 | 3050 | 0.260 |
Why?
|
| Physical Examination | 3 | 2014 | 164 | 0.250 |
Why?
|
| Databases, Factual | 5 | 2018 | 1169 | 0.250 |
Why?
|
| Aortic Rupture | 2 | 2022 | 118 | 0.250 |
Why?
|
| Glomerular Filtration Rate | 1 | 2008 | 481 | 0.250 |
Why?
|
| Blood Transfusion | 3 | 2017 | 302 | 0.250 |
Why?
|
| Gait | 2 | 2016 | 145 | 0.240 |
Why?
|
| Rivaroxaban | 2 | 2022 | 55 | 0.230 |
Why?
|
| Patient Education as Topic | 2 | 2020 | 441 | 0.230 |
Why?
|
| Embolism | 1 | 2024 | 49 | 0.230 |
Why?
|
| Thromboangiitis Obliterans | 1 | 2003 | 1 | 0.220 |
Why?
|
| Total Quality Management | 1 | 2003 | 26 | 0.220 |
Why?
|
| Texas | 5 | 2022 | 3548 | 0.220 |
Why?
|
| Emergencies | 2 | 2015 | 175 | 0.220 |
Why?
|
| Sex Distribution | 2 | 2021 | 294 | 0.220 |
Why?
|
| Aspirin | 2 | 2022 | 224 | 0.210 |
Why?
|
| Early Ambulation | 1 | 2022 | 8 | 0.210 |
Why?
|
| Pandemics | 2 | 2021 | 1105 | 0.210 |
Why?
|
| Cost-Benefit Analysis | 2 | 2016 | 499 | 0.210 |
Why?
|
| Retreatment | 3 | 2019 | 88 | 0.210 |
Why?
|
| Graft Occlusion, Vascular | 3 | 2019 | 95 | 0.210 |
Why?
|
| Prevalence | 5 | 2021 | 2403 | 0.210 |
Why?
|
| Negative-Pressure Wound Therapy | 4 | 2010 | 16 | 0.210 |
Why?
|
| Geriatric Assessment | 2 | 2020 | 169 | 0.200 |
Why?
|
| Arm | 1 | 2002 | 76 | 0.200 |
Why?
|
| Disease-Free Survival | 4 | 2018 | 860 | 0.200 |
Why?
|
| Scholarly Communication | 1 | 2021 | 7 | 0.200 |
Why?
|
| Staphylococcal Infections | 1 | 2007 | 553 | 0.200 |
Why?
|
| Hemangiosarcoma | 1 | 2022 | 38 | 0.190 |
Why?
|
| Biomarkers | 4 | 2020 | 2943 | 0.190 |
Why?
|
| Skin Neoplasms | 1 | 2008 | 802 | 0.190 |
Why?
|
| Congresses as Topic | 3 | 2019 | 167 | 0.190 |
Why?
|
| Computed Tomography Angiography | 3 | 2018 | 195 | 0.190 |
Why?
|
| Certification | 2 | 2020 | 68 | 0.190 |
Why?
|
| Iatrogenic Disease | 1 | 2021 | 132 | 0.180 |
Why?
|
| United Kingdom | 2 | 2020 | 195 | 0.180 |
Why?
|
| Global Health | 3 | 2020 | 557 | 0.180 |
Why?
|
| Hospitals | 2 | 2022 | 397 | 0.180 |
Why?
|
| Health Plan Implementation | 1 | 2020 | 42 | 0.180 |
Why?
|
| Judgment | 1 | 2020 | 35 | 0.180 |
Why?
|
| Sex Factors | 4 | 2024 | 1257 | 0.180 |
Why?
|
| Guidelines as Topic | 2 | 2020 | 197 | 0.180 |
Why?
|
| Exercise Therapy | 2 | 2022 | 150 | 0.170 |
Why?
|
| Injury Severity Score | 3 | 2017 | 219 | 0.170 |
Why?
|
| Clinical Decision-Making | 2 | 2019 | 266 | 0.170 |
Why?
|
| Clinical Competence | 3 | 2020 | 978 | 0.170 |
Why?
|
| Young Adult | 7 | 2019 | 8865 | 0.170 |
Why?
|
| Forecasting | 2 | 2019 | 355 | 0.170 |
Why?
|
| Professional-Patient Relations | 1 | 2020 | 85 | 0.170 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2008 | 715 | 0.170 |
Why?
|
| Surgical Procedures, Operative | 1 | 2021 | 182 | 0.170 |
Why?
|
| Centralized Hospital Services | 1 | 2019 | 5 | 0.170 |
Why?
|
| Regional Health Planning | 1 | 2019 | 6 | 0.170 |
Why?
|
| Home Care Services | 1 | 2020 | 67 | 0.170 |
Why?
|
| Social Media | 1 | 2021 | 107 | 0.170 |
Why?
|
| Collateral Circulation | 2 | 2017 | 45 | 0.160 |
Why?
|
| Health Services Research | 1 | 2020 | 187 | 0.160 |
Why?
|
| Wearable Electronic Devices | 1 | 2020 | 101 | 0.160 |
Why?
|
| Consensus | 4 | 2023 | 612 | 0.160 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 141 | 0.160 |
Why?
|
| Research | 1 | 2020 | 263 | 0.160 |
Why?
|
| Medical History Taking | 3 | 2014 | 106 | 0.150 |
Why?
|
| Clinical Trials as Topic | 2 | 2021 | 1088 | 0.150 |
Why?
|
| Endarterectomy, Carotid | 1 | 2019 | 92 | 0.150 |
Why?
|
| Elective Surgical Procedures | 2 | 2017 | 161 | 0.150 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2022 | 257 | 0.150 |
Why?
|
| Catheters, Indwelling | 1 | 2019 | 156 | 0.150 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2018 | 28 | 0.150 |
Why?
|
| Thoracic Injuries | 1 | 2018 | 91 | 0.150 |
Why?
|
| Benchmarking | 3 | 2021 | 132 | 0.150 |
Why?
|
| Prospective Studies | 8 | 2024 | 6028 | 0.150 |
Why?
|
| Ankle Joint | 1 | 2017 | 35 | 0.150 |
Why?
|
| Walking | 2 | 2016 | 206 | 0.140 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2022 | 367 | 0.140 |
Why?
|
| Ligation | 2 | 2011 | 132 | 0.140 |
Why?
|
| Age Factors | 4 | 2017 | 2801 | 0.140 |
Why?
|
| Splanchnic Circulation | 1 | 2017 | 52 | 0.140 |
Why?
|
| Abdominal Injuries | 1 | 2018 | 108 | 0.140 |
Why?
|
| Mesenteric Arteries | 1 | 2017 | 56 | 0.140 |
Why?
|
| Computer Simulation | 2 | 2019 | 637 | 0.140 |
Why?
|
| Respiratory Tract Diseases | 1 | 2017 | 76 | 0.140 |
Why?
|
| Qualitative Research | 1 | 2020 | 522 | 0.140 |
Why?
|
| Angiography | 2 | 2017 | 215 | 0.140 |
Why?
|
| Regional Medical Programs | 1 | 2016 | 16 | 0.140 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 1 | 2016 | 5 | 0.140 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 477 | 0.140 |
Why?
|
| Diabetes Complications | 3 | 2014 | 196 | 0.140 |
Why?
|
| Propensity Score | 2 | 2015 | 206 | 0.140 |
Why?
|
| Video Games | 1 | 2017 | 88 | 0.130 |
Why?
|
| Models, Economic | 1 | 2016 | 51 | 0.130 |
Why?
|
| Brain Injuries | 1 | 2022 | 734 | 0.130 |
Why?
|
| Pilot Projects | 2 | 2017 | 1387 | 0.130 |
Why?
|
| Cost Savings | 1 | 2016 | 69 | 0.130 |
Why?
|
| Arteriosclerosis Obliterans | 1 | 2016 | 1 | 0.130 |
Why?
|
| Communication | 1 | 2020 | 512 | 0.130 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2016 | 45 | 0.130 |
Why?
|
| Markov Chains | 1 | 2016 | 83 | 0.130 |
Why?
|
| Hemoglobins | 1 | 2017 | 300 | 0.130 |
Why?
|
| Debridement | 3 | 2010 | 85 | 0.130 |
Why?
|
| Pancreatic Neoplasms | 1 | 2022 | 687 | 0.130 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 180 | 0.130 |
Why?
|
| Alloys | 2 | 2013 | 16 | 0.130 |
Why?
|
| Adolescent | 8 | 2022 | 19083 | 0.130 |
Why?
|
| Transducers | 1 | 2015 | 25 | 0.120 |
Why?
|
| Academic Medical Centers | 2 | 2015 | 298 | 0.120 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2007 | 169 | 0.120 |
Why?
|
| Subclavian Artery | 1 | 2015 | 71 | 0.120 |
Why?
|
| Vocabulary, Controlled | 1 | 2015 | 13 | 0.120 |
Why?
|
| Delayed Diagnosis | 1 | 2016 | 120 | 0.120 |
Why?
|
| Oxygen | 2 | 2016 | 540 | 0.120 |
Why?
|
| Stress, Physiological | 1 | 2017 | 264 | 0.120 |
Why?
|
| Patient Safety | 1 | 2019 | 390 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 360 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 376 | 0.120 |
Why?
|
| Respiration, Artificial | 1 | 2017 | 455 | 0.120 |
Why?
|
| Postoperative Hemorrhage | 1 | 2015 | 86 | 0.120 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 594 | 0.120 |
Why?
|
| Postural Balance | 1 | 2015 | 124 | 0.120 |
Why?
|
| Exercise | 1 | 2020 | 811 | 0.110 |
Why?
|
| Oximetry | 1 | 2015 | 158 | 0.110 |
Why?
|
| Intubation, Intratracheal | 1 | 2017 | 291 | 0.110 |
Why?
|
| Models, Biological | 1 | 2019 | 1442 | 0.110 |
Why?
|
| Combined Modality Therapy | 2 | 2016 | 1240 | 0.110 |
Why?
|
| Ambulatory Care | 1 | 2017 | 376 | 0.110 |
Why?
|
| Disease Management | 2 | 2020 | 516 | 0.110 |
Why?
|
| Faculty, Medical | 1 | 2017 | 264 | 0.110 |
Why?
|
| Intensive Care Units | 1 | 2017 | 484 | 0.110 |
Why?
|
| Cardiology | 1 | 2019 | 472 | 0.110 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2014 | 61 | 0.110 |
Why?
|
| Therapeutic Irrigation | 2 | 2010 | 43 | 0.110 |
Why?
|
| Skin Transplantation | 1 | 2014 | 60 | 0.110 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2013 | 57 | 0.110 |
Why?
|
| Point-of-Care Testing | 2 | 2023 | 27 | 0.110 |
Why?
|
| Patient Admission | 1 | 2014 | 184 | 0.110 |
Why?
|
| Hospital Costs | 1 | 2014 | 178 | 0.110 |
Why?
|
| Embolization, Therapeutic | 2 | 2017 | 226 | 0.100 |
Why?
|
| Child | 7 | 2023 | 24205 | 0.100 |
Why?
|
| Linear Models | 1 | 2014 | 671 | 0.100 |
Why?
|
| Remission Induction | 1 | 2013 | 300 | 0.100 |
Why?
|
| Pneumonia | 1 | 2015 | 325 | 0.100 |
Why?
|
| Intraoperative Period | 1 | 2012 | 72 | 0.100 |
Why?
|
| Knowledge | 1 | 2011 | 46 | 0.100 |
Why?
|
| Sensitivity and Specificity | 3 | 2012 | 2024 | 0.100 |
Why?
|
| Secondary Prevention | 1 | 2013 | 211 | 0.100 |
Why?
|
| Tibia | 1 | 2012 | 70 | 0.100 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 606 | 0.100 |
Why?
|
| Hemodynamics | 2 | 2013 | 850 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 939 | 0.090 |
Why?
|
| Emergency Service, Hospital | 2 | 2017 | 1069 | 0.090 |
Why?
|
| Equipment Design | 2 | 2015 | 600 | 0.090 |
Why?
|
| Brachial Artery | 2 | 2008 | 38 | 0.090 |
Why?
|
| Quality Improvement | 1 | 2016 | 624 | 0.090 |
Why?
|
| Career Choice | 1 | 2011 | 143 | 0.090 |
Why?
|
| Feasibility Studies | 3 | 2019 | 753 | 0.090 |
Why?
|
| Life Tables | 2 | 2017 | 29 | 0.090 |
Why?
|
| Disease Progression | 2 | 2015 | 2027 | 0.090 |
Why?
|
| Kidney Failure, Chronic | 3 | 2019 | 866 | 0.090 |
Why?
|
| Biopsy | 1 | 2013 | 1239 | 0.090 |
Why?
|
| Methacrylates | 1 | 2009 | 16 | 0.080 |
Why?
|
| Acute Disease | 2 | 2024 | 1090 | 0.080 |
Why?
|
| Aorta | 2 | 2023 | 541 | 0.080 |
Why?
|
| Comorbidity | 1 | 2014 | 1498 | 0.080 |
Why?
|
| Product Labeling | 1 | 2008 | 3 | 0.080 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2009 | 26 | 0.080 |
Why?
|
| Endarterectomy | 1 | 2008 | 22 | 0.080 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 744 | 0.080 |
Why?
|
| Cooperative Behavior | 3 | 2019 | 219 | 0.080 |
Why?
|
| Thigh | 1 | 2008 | 50 | 0.080 |
Why?
|
| Stroke | 1 | 2016 | 958 | 0.080 |
Why?
|
| Indium Radioisotopes | 1 | 2008 | 10 | 0.080 |
Why?
|
| Wounds, Gunshot | 1 | 2009 | 137 | 0.080 |
Why?
|
| Telemedicine | 1 | 2014 | 426 | 0.080 |
Why?
|
| Forearm | 1 | 2008 | 44 | 0.070 |
Why?
|
| Hospitals, High-Volume | 2 | 2019 | 35 | 0.070 |
Why?
|
| Diabetic Neuropathies | 1 | 2008 | 58 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2013 | 519 | 0.070 |
Why?
|
| Colectomy | 1 | 2008 | 75 | 0.070 |
Why?
|
| Hand | 1 | 2008 | 102 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 3 | 2010 | 2397 | 0.070 |
Why?
|
| Coronary Restenosis | 1 | 2007 | 20 | 0.070 |
Why?
|
| Wounds and Injuries | 1 | 2010 | 363 | 0.070 |
Why?
|
| Polytetrafluoroethylene | 2 | 2008 | 80 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 423 | 0.070 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2008 | 193 | 0.070 |
Why?
|
| Europe | 2 | 2019 | 376 | 0.070 |
Why?
|
| Surgical Flaps | 1 | 2008 | 206 | 0.070 |
Why?
|
| Blood Flow Velocity | 3 | 2017 | 448 | 0.070 |
Why?
|
| Device Removal | 1 | 2008 | 223 | 0.070 |
Why?
|
| Glasgow Coma Scale | 2 | 2017 | 199 | 0.070 |
Why?
|
| Brachytherapy | 1 | 2007 | 74 | 0.070 |
Why?
|
| Infant | 3 | 2018 | 12321 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2020 | 4708 | 0.070 |
Why?
|
| Endocarditis, Bacterial | 1 | 2007 | 129 | 0.060 |
Why?
|
| Child, Preschool | 3 | 2018 | 13859 | 0.060 |
Why?
|
| Colonoscopy | 1 | 2008 | 239 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2013 | 828 | 0.060 |
Why?
|
| Insulin | 1 | 2010 | 1197 | 0.060 |
Why?
|
| Administration, Topical | 3 | 2010 | 144 | 0.060 |
Why?
|
| Stomach | 1 | 2007 | 271 | 0.060 |
Why?
|
| Renal Artery Obstruction | 1 | 2005 | 41 | 0.060 |
Why?
|
| Patient Care Planning | 1 | 2005 | 123 | 0.060 |
Why?
|
| Vacuum | 1 | 2004 | 11 | 0.060 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 3377 | 0.060 |
Why?
|
| Fasciotomy | 1 | 2024 | 27 | 0.060 |
Why?
|
| Contraindications | 1 | 2004 | 77 | 0.060 |
Why?
|
| Research Design | 1 | 2008 | 688 | 0.060 |
Why?
|
| Long-Term Care | 1 | 2003 | 71 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2016 | 3260 | 0.050 |
Why?
|
| Nutrition Policy | 1 | 2023 | 100 | 0.050 |
Why?
|
| Probability | 1 | 2003 | 322 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2022 | 66 | 0.050 |
Why?
|
| Reference Values | 1 | 2003 | 696 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2023 | 278 | 0.050 |
Why?
|
| Perioperative Care | 1 | 2004 | 196 | 0.050 |
Why?
|
| Health Status Disparities | 1 | 2024 | 220 | 0.050 |
Why?
|
| Doxycycline | 1 | 2002 | 117 | 0.050 |
Why?
|
| American Heart Association | 1 | 2023 | 294 | 0.050 |
Why?
|
| Nutritional Status | 1 | 2023 | 303 | 0.050 |
Why?
|
| Catheterization | 1 | 2023 | 234 | 0.050 |
Why?
|
| Attitude to Computers | 1 | 2021 | 49 | 0.050 |
Why?
|
| Patient Advocacy | 1 | 2021 | 62 | 0.050 |
Why?
|
| Pancreatectomy | 1 | 2022 | 135 | 0.050 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2022 | 92 | 0.050 |
Why?
|
| Conflict of Interest | 1 | 2021 | 67 | 0.050 |
Why?
|
| Preoperative Care | 1 | 2003 | 350 | 0.050 |
Why?
|
| Pancreas | 1 | 2022 | 210 | 0.050 |
Why?
|
| Organizational Innovation | 1 | 2020 | 44 | 0.040 |
Why?
|
| Comparative Effectiveness Research | 1 | 2020 | 66 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2021 | 272 | 0.040 |
Why?
|
| Therapies, Investigational | 1 | 2020 | 13 | 0.040 |
Why?
|
| Metals | 1 | 2020 | 61 | 0.040 |
Why?
|
| Spatial Analysis | 1 | 2019 | 21 | 0.040 |
Why?
|
| Review Literature as Topic | 1 | 2020 | 45 | 0.040 |
Why?
|
| Hospitals, Low-Volume | 1 | 2019 | 30 | 0.040 |
Why?
|
| Risk | 2 | 2015 | 750 | 0.040 |
Why?
|
| Transportation | 1 | 2019 | 27 | 0.040 |
Why?
|
| Geography | 1 | 2019 | 113 | 0.040 |
Why?
|
| Organ Sparing Treatments | 1 | 2019 | 34 | 0.040 |
Why?
|
| Interdisciplinary Communication | 2 | 2010 | 134 | 0.040 |
Why?
|
| Heart Function Tests | 1 | 2019 | 57 | 0.040 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2019 | 23 | 0.040 |
Why?
|
| Global Burden of Disease | 1 | 2019 | 25 | 0.040 |
Why?
|
| Thrombosis | 1 | 2024 | 520 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2022 | 459 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2020 | 330 | 0.040 |
Why?
|
| Workload | 2 | 2011 | 147 | 0.040 |
Why?
|
| North America | 1 | 2019 | 234 | 0.040 |
Why?
|
| Informed Consent | 1 | 2021 | 342 | 0.040 |
Why?
|
| Biofeedback, Psychology | 1 | 2017 | 33 | 0.040 |
Why?
|
| Referral and Consultation | 2 | 2014 | 527 | 0.040 |
Why?
|
| Range of Motion, Articular | 1 | 2017 | 73 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 131 | 0.040 |
Why?
|
| Electromyography | 1 | 2017 | 160 | 0.040 |
Why?
|
| Biomechanical Phenomena | 1 | 2017 | 246 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2017 | 197 | 0.030 |
Why?
|
| Walking Speed | 1 | 2016 | 15 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 288 | 0.030 |
Why?
|
| Accelerometry | 1 | 2016 | 59 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2017 | 284 | 0.030 |
Why?
|
| Torso | 1 | 2015 | 12 | 0.030 |
Why?
|
| Ankle | 1 | 2016 | 28 | 0.030 |
Why?
|
| Monitoring, Ambulatory | 1 | 2015 | 54 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2015 | 145 | 0.030 |
Why?
|
| Costa Rica | 1 | 2015 | 10 | 0.030 |
Why?
|
| Miniaturization | 1 | 2015 | 27 | 0.030 |
Why?
|
| Hypesthesia | 1 | 2014 | 10 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2016 | 352 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2015 | 77 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2015 | 118 | 0.030 |
Why?
|
| Heart Rate | 1 | 2017 | 585 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2016 | 1011 | 0.030 |
Why?
|
| Postoperative Care | 2 | 2009 | 293 | 0.030 |
Why?
|
| ROC Curve | 1 | 2015 | 557 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2015 | 3662 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2015 | 242 | 0.030 |
Why?
|
| Sirolimus | 1 | 2015 | 220 | 0.030 |
Why?
|
| Motor Activity | 1 | 2016 | 520 | 0.030 |
Why?
|
| Inpatients | 1 | 2017 | 492 | 0.030 |
Why?
|
| Medicaid | 1 | 2015 | 244 | 0.030 |
Why?
|
| Skin | 1 | 2016 | 505 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 872 | 0.020 |
Why?
|
| Medicare | 1 | 2015 | 423 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2015 | 1470 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2017 | 961 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1684 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 645 | 0.020 |
Why?
|
| Operating Room Information Systems | 1 | 2010 | 1 | 0.020 |
Why?
|
| Feedback | 1 | 2011 | 163 | 0.020 |
Why?
|
| Infectious Disease Medicine | 1 | 2010 | 12 | 0.020 |
Why?
|
| Organizational Objectives | 1 | 2010 | 33 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2010 | 22 | 0.020 |
Why?
|
| Models, Organizational | 1 | 2010 | 40 | 0.020 |
Why?
|
| Bandages | 1 | 2010 | 56 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 2010 | 95 | 0.020 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2010 | 70 | 0.020 |
Why?
|
| Cotton Fiber | 1 | 2009 | 1 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2011 | 449 | 0.020 |
Why?
|
| Consumer Product Safety | 1 | 2009 | 30 | 0.020 |
Why?
|
| Quality of Life | 1 | 2019 | 1931 | 0.020 |
Why?
|
| Powders | 1 | 2009 | 25 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2011 | 326 | 0.020 |
Why?
|
| Hospitalization | 1 | 2017 | 1733 | 0.020 |
Why?
|
| Aging | 1 | 2015 | 1172 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2009 | 149 | 0.020 |
Why?
|
| Groin | 1 | 2008 | 15 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2010 | 384 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2014 | 753 | 0.020 |
Why?
|
| Learning | 1 | 2011 | 361 | 0.020 |
Why?
|
| Aortography | 1 | 2008 | 200 | 0.020 |
Why?
|
| Emergency Treatment | 1 | 2008 | 84 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2010 | 391 | 0.020 |
Why?
|
| Curriculum | 1 | 2011 | 722 | 0.020 |
Why?
|
| Prosthesis-Related Infections | 1 | 2008 | 176 | 0.020 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2007 | 172 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2008 | 266 | 0.020 |
Why?
|
| Hypertension, Renovascular | 1 | 2005 | 29 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2007 | 418 | 0.010 |
Why?
|
| Critical Care | 1 | 2008 | 650 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2002 | 137 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2002 | 252 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2002 | 468 | 0.010 |
Why?
|